WeVote
Log In

Bill

Bill

A 771

Requires insurance coverage for early egg and peanut allergen introduction dietary supplements for infants at no cost

2025 Regular Session Introduced by Vivian Cook and 6 co-sponsors

Requires insurance to cover dietary supplements for early egg and peanut allergen introduction in infants, with no out-of-pocket costs for families.

PRINT NUMBER 771A
0
WeVote Research Nonpartisan
Bill Summary · A 771

Summary of Bill A 771

Overview

House Bill A 771 would require insurance coverage for dietary supplements used to introduce egg and peanut allergens to infants, with no out-of-pocket costs for the insured. The measure aims to facilitate early allergen exposure as part of infant nutrition and allergy prevention, by ensuring families have access to these supplements through their insurance plans.

Purpose and intent

  • Promote early introduction of key allergens (egg and peanut) in infancy as a potential strategy to reduce later allergy development.
  • Remove financial barriers by prohibiting cost-sharing (copays, deductibles, or coinsurance) for approved dietary supplements used for this purpose.
  • Align with preventive health goals by integrating coverage for preventive dietary interventions into standard insurance offerings.

Key provisions (as indicated by the bill’s title and summary)

  • Insurance coverage requirement: Health insurance plans would be obligated to cover dietary supplements intended for the early introduction of egg and peanut allergens in infants.
  • No cost-sharing: Such coverage would be provided at no cost to the insured (no out-of-pocket costs).
  • Scope of products: Covers dietary supplements specifically designed for early egg and peanut allergen introduction in infants. (Exact definitions and eligible products would be specified in the bill’s text.)
  • Implementation: The bill would set forth how insurers must reimburse or cover these products, and any related administrative processes. Details would be defined in the final enacted language.

Affected parties

  • Infants and their families who purchase these dietary supplements for early allergen introduction.
  • Private health insurers and public insurers subject to the new coverage requirement.
  • Healthcare providers who advise families on early allergen introduction and prescribe or recommend these supplements.

Procedural status and timeline

  • Introduced: January 8, 2025.
  • Referred to Committee: Insurance (January 8, 2025).
  • Legislative actions: On May 15, 2025, amendments and recommitments to the Insurance Committee, and publication of Print Number 771A (the amended form).
  • Related companion: S 7915 (in the Senate) indicates cross-chamber sponsorship and parallel legislation.

Sponsorship

  • Primary sponsor: Linda Rosenthal.
  • Cosponsors: MaryJane Shimsky, Charles Lavine, Phil Steck, Kalman Yeger, Vivian Cook, Jen Lunsford.

Related legislation

  • Companion bill: S 7915 (listed as a companion in the Senate).

Potential impact and considerations

  • Access and equity: Families would have easier access to preventive nutrition options without cost barriers.
  • Budget and premiums: Insurers may adjust plan designs or premiums to accommodate expanded coverage; exact financial impact would depend on implementation details and product definitions.
  • Implementation: Final language would clarify eligible products, definitions, and any required regulatory or administrative steps for rollout.

Next steps

  • Review the full bill text for precise definitions, eligibility criteria, and implementation timelines.
  • Monitor Senate companion (S 7915) for parallel actions and eventual conference or enactment decisions.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.